These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20350005)

  • 21. Effect of macrophage overexpression of murine liver X receptor-alpha (LXR-alpha) on atherosclerosis in LDL-receptor deficient mice.
    Teupser D; Kretzschmar D; Tennert C; Burkhardt R; Wilfert W; Fengler D; Naumann R; Sippel AE; Thiery J
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2009-15. PubMed ID: 18787185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular Cholesterol Accumulation Facilitates Ubiquitination and Lysosomal Degradation of Cell Surface-Resident ABCA1.
    Mizuno T; Hayashi H; Kusuhara H
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1347-56. PubMed ID: 25838426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of liver x receptor/retinoid X receptor-mediated transcription contributes to the proatherogenic effects of arsenic in macrophages in vitro.
    Padovani AM; Molina MF; Mann KK
    Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1228-36. PubMed ID: 20339114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EP 80317, a CD36 selective ligand, promotes reverse cholesterol transport in apolipoprotein E-deficient mice.
    Bujold K; Mellal K; Zoccal KF; Rhainds D; Brissette L; Febbraio M; Marleau S; Ong H
    Atherosclerosis; 2013 Aug; 229(2):408-14. PubMed ID: 23880196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin-(1-7) stimulates cholesterol efflux from angiotensin II-treated cholesterol-loaded THP-1 macrophages through the suppression of p38 and c-Jun N-terminal kinase signaling.
    Yang HY; Bian YF; Xiao CS; Liang B; Zhang N; Gao F; Yang ZM
    Mol Med Rep; 2015 Jul; 12(1):1387-92. PubMed ID: 25779847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin-(1-7) upregulates expression of adenosine triphosphate-binding cassette transporter A1 and adenosine triphosphate-binding cassette transporter G1 through the Mas receptor through the liver X receptor alpha signalling pathway in THP-1 macrophages treated with angiotensin-II.
    Liang B; Wang X; Bian Y; Yang H; Liu M; Bai R; Yang Z; Xiao C
    Clin Exp Pharmacol Physiol; 2014 Dec; 41(12):1023-30. PubMed ID: 25225013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA topoisomerase II inhibitors induce macrophage ABCA1 expression and cholesterol efflux-an LXR-dependent mechanism.
    Zhang L; Jiang M; Shui Y; Chen Y; Wang Q; Hu W; Ma X; Li X; Liu X; Cao X; Liu M; Duan Y; Han J
    Biochim Biophys Acta; 2013 Jun; 1831(6):1134-45. PubMed ID: 23466610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidized LDL upregulated ATP binding cassette transporter-1 in THP-1 macrophages.
    Tang CK; Yi GH; Yang JH; Liu LS; Wang Z; Ruan CG; Yang YZ
    Acta Pharmacol Sin; 2004 May; 25(5):581-6. PubMed ID: 15132822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pitavastatin effect on ATP binding cassette A1-mediated lipid efflux from macrophages: evidence for liver X receptor (LXR)-dependent and LXR-independent mechanisms of activation by cAMP.
    Zanotti I; Potì F; Favari E; Steffensen KR; Gustafsson JA; Bernini F
    J Pharmacol Exp Ther; 2006 Apr; 317(1):395-401. PubMed ID: 16415093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biarylether amide quinolines as liver X receptor agonists.
    Bernotas RC; Singhaus RR; Kaufman DH; Ullrich J; Fletcher H; Quinet E; Nambi P; Unwalla R; Wilhelmsson A; Goos-Nilsson A; Farnegardh M; Wrobel J
    Bioorg Med Chem; 2009 Feb; 17(4):1663-70. PubMed ID: 19162487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low dose of the liver X receptor agonist, AZ876, reduces atherosclerosis in APOE*3Leiden mice without affecting liver or plasma triglyceride levels.
    van der Hoorn J; Lindén D; Lindahl U; Bekkers M; Voskuilen M; Nilsson R; Oscarsson J; Lindstedt E; Princen H
    Br J Pharmacol; 2011 Apr; 162(7):1553-63. PubMed ID: 21175581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of p160 coactivator complex in the activation of liver X receptor.
    Huuskonen J; Fielding PE; Fielding CJ
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):703-8. PubMed ID: 14764426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atorvastatin inhibits ABCA1 expression and cholesterol efflux in THP-1 macrophages by an LXR-dependent pathway.
    Qiu G; Hill JS
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):388-95. PubMed ID: 18427282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue-specific induction of intestinal ABCA1 expression with a liver X receptor agonist raises plasma HDL cholesterol levels.
    Brunham LR; Kruit JK; Pape TD; Parks JS; Kuipers F; Hayden MR
    Circ Res; 2006 Sep; 99(7):672-4. PubMed ID: 16946132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel liver X receptor agonist establishes species differences in the regulation of cholesterol 7alpha-hydroxylase (CYP7a).
    Menke JG; Macnaul KL; Hayes NS; Baffic J; Chao YS; Elbrecht A; Kelly LJ; Lam MH; Schmidt A; Sahoo S; Wang J; Wright SD; Xin P; Zhou G; Moller DE; Sparrow CP
    Endocrinology; 2002 Jul; 143(7):2548-58. PubMed ID: 12072387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PAPP-A negatively regulates ABCA1, ABCG1 and SR-B1 expression by inhibiting LXRα through the IGF-I-mediated signaling pathway.
    Tang SL; Chen WJ; Yin K; Zhao GJ; Mo ZC; Lv YC; Ouyang XP; Yu XH; Kuang HJ; Jiang ZS; Fu YC; Tang CK
    Atherosclerosis; 2012 Jun; 222(2):344-54. PubMed ID: 22503545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arctigenin promotes cholesterol efflux from THP-1 macrophages through PPAR-γ/LXR-α signaling pathway.
    Xu X; Li Q; Pang L; Huang G; Huang J; Shi M; Sun X; Wang Y
    Biochem Biophys Res Commun; 2013 Nov; 441(2):321-6. PubMed ID: 24140409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IFN-gamma down-regulates ABCA1 expression by inhibiting LXRalpha in a JAK/STAT signaling pathway-dependent manner.
    Hao XR; Cao DL; Hu YW; Li XX; Liu XH; Xiao J; Liao DF; Xiang J; Tang CK
    Atherosclerosis; 2009 Apr; 203(2):417-28. PubMed ID: 18789440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage LXRα gene therapy ameliorates atherosclerosis as well as hypertriglyceridemia in LDLR(-/-) mice.
    Li G; Biju KC; Xu X; Zhou Q; Chen C; Valente AJ; He W; Reddick RL; Freeman GL; Ahuja SS; Clark RA; Li S
    Gene Ther; 2011 Aug; 18(8):835-41. PubMed ID: 21390069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligation of RAGE with ligand S100B attenuates ABCA1 expression in monocytes.
    Kumar P; Raghavan S; Shanmugam G; Shanmugam N
    Metabolism; 2013 Aug; 62(8):1149-58. PubMed ID: 23523156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.